As BioMendics prepares to share its progress during the 2026 J.P. Morgan Healthcare Conference and Biotech Showcase, the Ohio-based biotech is advancing what could become the first disease-modifying ...
It’s for cases like Mark’s and the many out there that I’m especially disappointed with the latest White Paper from the ...
Two scales assess a romantic partner’s value: a cognitive scale that measures traits and achievements, and evaluative scale ...
Johnson & Johnson today announced positive topline results from the Phase 2b JASMINE (NCT04882878) study of adults living with systemic lupus erythematosus (SLE) and the initiation of a Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback